Endovascular Therapy in Stroke: Much Evidence and Few Trained Operators

Endovascular therapy is now considered as the standard of care for acute ischemic stroke caused by large vessel occlusion. The time between symptoms onset and reperfusion emerges as the most determinant factor for good clinical outcomes, much more strongly than even in acute myocardial infarction. The saying “time is brain” is even more relevant than “time is myocardium.” Sites with trained interventional neurologists are scarce all over the world, something that prompts the following spontaneous question: should we, interventional cardiologists, be involved in the treatment of stroke?

Terapia endovascular en stroke: mucha evidencia y pocos operadores entrenadosWhile the discussion continues, we should at least be informed on this subject matter, so as to be ready to eventually go into the cath lab.

 

This study developed a score to predict which patients would benefit the most from endovascular therapy, fundamentally targeting variables easy to analyze: age and stroke severity.

 

Researchers analyzed a total of 4079 patients admitted with acute ischemic stroke, who were included in the Paris Stroke Consortium registry. A score was developed based on age (1 point per decade ≥50 years of age) and severity (2 points per every 5 points on the National Institutes of Health Stroke Scale [NIHSS]). Its aim was to predict spontaneous prognosis. The primary outcome was an improvement in the modified Rankin Scale at 90 days after endovascular therapy in patients with low, intermediate, or high scores.


Read also: New Ultra-Thin-Strut DES: Do They Outperform Second-Generation DES?


In patients who did not undergo endovascular treatment, scores <8 were predictive of good outcomes (Rankin Scale score: 0–2), whereas scores >12 were predictive of much poorer outcomes (Rankin Scale score: 4–6).

 

Endovascular therapy was associated with better outcomes in patients with scores >12 (p < 0.001) and intermediate scores (between 8 and 12), but not in patients with low scores (<8).


Read also: Treating Tricuspid and Mitral Valves with MitraClip Improves Quality of Life.


If interventional cardiologists intend to get involved in the treatment of these patients, they should receive training on the assessment of these scores (the NIHSS, for starters) and of imaging scans (computerized axial tomography, nuclear magnetic resonance), and, of course, on actual endovascular therapy techniques.

 

Conclusion

Patients admitted with acute ischemic stroke can be stratified with this new, easy-to-calculate score. Patients who are older and with more severe stroke will benefit the most from endovascular therapy, while patients who are younger and with less severe stroke will derive no benefit from it.

 

Original title: Efficacy of Endovascular Therapy in Acute Ischemic Stroke Depends on Age and Clinical Severity.

Reference: Raphaël Le Bouc et al. Stroke. 2018 Jul;49(7):1686-1694.

 

1686-full-abierto-para-publicar


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...